Download presentation
Presentation is loading. Please wait.
Published byMabel Nicholson Modified over 6 years ago
1
Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation Victoria Jacobs, NP, Heidi T. May, PhD, Tami L. Bair, RN, Brian G. Crandall, MD, Michael J. Cutler, DO, PhD, John D. Day, MD, Charles Mallender, MD, Jeffrey S. Osborn, MD, Scott M. Stevens, MD, J. Peter Weiss, MD, Scott C. Woller, MD, T. Jared Bunch, MD American Journal of Cardiology Volume 118, Issue 2, Pages (July 2016) DOI: /j.amjcard Copyright © 2016 Elsevier Inc. Terms and Conditions
2
Figure 1 Survival curve free of new stroke or TIA in patients with AF treated with DOACs versus warfarin. American Journal of Cardiology , DOI: ( /j.amjcard ) Copyright © 2016 Elsevier Inc. Terms and Conditions
3
Figure 2 Survival curve free of major bleeds in patients with AF treated with DOACs versus warfarin. American Journal of Cardiology , DOI: ( /j.amjcard ) Copyright © 2016 Elsevier Inc. Terms and Conditions
4
Figure 3 Survival curve free of total mortality in patients with AF treated with DOACs versus warfarin. American Journal of Cardiology , DOI: ( /j.amjcard ) Copyright © 2016 Elsevier Inc. Terms and Conditions
5
Figure 4 Long-term incident dementia events in patients with AF compared by DOACs and warfarin treatment. American Journal of Cardiology , DOI: ( /j.amjcard ) Copyright © 2016 Elsevier Inc. Terms and Conditions
6
Figure 5 Survival curve for composite outcome of dementia, stroke, and TIA among DOAC and warfarin groups. American Journal of Cardiology , DOI: ( /j.amjcard ) Copyright © 2016 Elsevier Inc. Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.